Close
  • Our mission
    • About the Dutch CardioVascular alliance
  • Our impact
    • Our priorities
  • Our projects
    • Our consortia
  • About us
    • Latest updates
    • Events
    • Partners
    • Vacancies
    • Management Team
    • Contact
    • ✉ Subscribe to newsletter
  • Our mission
    • About the Dutch CardioVascular alliance
  • Our impact
    • Our priorities
  • Our projects
    • Our consortia
  • About us
    • Latest updates
    • Events
    • Partners
    • Vacancies
    • Management Team
    • Contact
    • ✉ Subscribe to newsletter
  • Menu
  • Heart-Brain Connection crossroads (HBCx)
  • HBCx - Publications

HBCx - Publications

A selection:

  • CBF TAVI https://pubmed.ncbi.nlm.nih.gov/33068017/
  • Microinfarcts in COD https://pubmed.ncbi.nlm.nih.gov/33899560/
  • Cerebral arterial perforator on 7T MRI https://pubmed.ncbi.nlm.nih.gov/32810376/
  • Microinfarcts HF https://www.ncbi.nlm.nih.gov/pubmed/32331904
  • CBF en cognition https://pubmed.ncbi.nlm.nih.gov/32995468/
  • Sex differences https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447910/
  • Neural tract segementation https://pubmed.ncbi.nlm.nih.gov/32492510/
  • HBC clinic https://pubmed.ncbi.nlm.nih.gov/32125785/
  • Cognition baseline https://pubmed.ncbi.nlm.nih.gov/31684846/
  • CBF https://www.ncbi.nlm.nih.gov/pubmed/28588075
  • LV segmentation long axis https://www.ncbi.nlm.nih.gov/pubmed/28432954
  • Hypotension http://www.ncbi.nlm.nih.gov/pubmed/27727284
  • Vasoreactivity http://www.ncbi.nlm.nih.gov/pubmed/26586657
  • Vascular cognitive impairment https://www.ncbi.nlm.nih.gov/pubmed/29446769
  • Excersion-VCI design https://www.ncbi.nlm.nih.gov/pubmed/29067325
  • HBC1 Design https://pubmed.ncbi.nlm.nih.gov/29017156/
  • HBC approach http://www.ncbi.nlm.nih.gov/pubmed/25213769

Dutch

https://www.ntvg.nl/artikelen/risicos-van-vitamine-k-antagonisten-bij-cerebrale-microbloedingen/volledig

  • Home
  • About the Dutch CardioVascular Alliance
  • Our priorities
  • Latest updates
  • Partners
  • Vacancies
  • Contact
  • Subscribe to our newsletter
  • Follow us on LinkedIn